OPEN MIC NEXT IN HEALTH SERIES – No data, no health: Digital transformation of health systems

Date

23.10.2023 16:30 - 17:45

Location

Novartis Pavillon at St. Johanns-Hafen-Weg 5, 4056 Basel

Register

Despite digital transformation becoming a buzz word in recent years, health systems consider digital capabilities a path to improve their relationship with consumers. Spending on digital transformation exceeded $1.3 trillion worldwide and it is growing on a yearly basis, making the health sector ripe for the next wave of disruption.

Besides the latest technology and information systems, the digital future of healthcare encompasses various aspects of human-tech interaction. It illustrates how this interconnection may enable positive changes in population health, improve health systems’ agility, operational excellence, patient experience and reduce costs.

As healthcare providers, decision-makers and corporations work toward adapting their businesses, a systemic data-driven approach toward digital technologies will play an essential role in the transformation success. What are the key enablers of a cost-effective data-driven approach? How can we responsibly harvest data to learn from real-world evidence and drive improved patient outcomes? What are the best practices in digitalization operations and how do key players define the long-term strategic priorities while building public trust?

Open Mic Next in Health Series – No data, no health: Digital transformation of health systems
LIVE from Novartis Pavillon in Basel
23 October 2023, 16:30 – 17:45 CEST on site* and online

Participation is free, however registration is required before 16.10.2023 (on site).

On stage

Peter Speyer, Head of Data and Analytics at Novartis Foundation
Ana da Motta, Head of Healthcare Public Policy EMEA at AWS (Amazon Web Services)
Further key opinion leaders – to be announced soon

OPEN MIC NEXT IN HEALTH SERIES invites leaders from vastly different backgrounds to take the mic in a relaxing yet controversial conversation and share their views on the future of health. We welcome life sciences and healthcare disruptors to the Novartis Pavillon to discuss latest trends in digital health innovation.

Swiss Venture Capital Report TEST

The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". You can download it in our assets section.